PPAR ligand L-165041 ameliorates Western diet-induced hepatic

62
PPAR has been reported to be involved in developmental regulation (Braissant and 63 Wahli, 1998), energy homeostasis (Berger et al., 2005) , and lipid metabolism 64 (Leibowitz et al., 2000) . In the hepatic system, a synthetic PPAR ligand has been Nevertheless, a more defined role of PPAR in hepatic lipid metabolism under 71 pathologic conditions such as hepatic steatosis remains to be determined.
72
A high-fat diet can lead to the hepatic accumulation of dietary fat and cause
73
inflammation (Lavoie and Gauthier, 2006 was significantly lower than that in vehicle mice (Fig. 4B ). In addition, the expression 202 of ABCG1, which is known to be involved in cholesterol efflux, increased dramatically 203 with statistical significance (Fig. 4C ). An inflammatory response in the liver due to a 
314
Although we are not able to provide direct evidence in the present study, we Due to the complexity of the mechanisms that cause hepatic lipid accumulation, we were unable to identify a single major factor or mechanism responsible for the observed 327 inhibitory effect of L-165041 on hepatic lipid accumulation in our experimental setting.
328
In other words, there are many possible mechanisms that might explain the observe 329 effect of L-165041 in the present study and such mechanisms include food intake, normalized with respect to GAPDH. *Statistically significant compared to vehicle (P < IL-6, interleukin-6; TNF-, tumor necrosis factor-alpha; GAPDH, glyceraldehyde 3-5 phosphate dehydrogenase. Table   1   Table 2 12
Effect of L-165041 on serum lipid profiles and tissue weight of LDLR -/-mice 
